Formulary Monographs [CARBOPLATIN, 1000]

CARBOPLATIN
ANTINEOPLASTICS
Advanced ovarian cancers and of small-cell lung cancer.
As for cisplatin. Myelosuppression may be more severe than cisplatin and prolonged in patients with impaired renal function.
Adult: dose of carboplatin is determined according to renal function rather than body surface area.
Carboplatin can cause fetal toxicity when administered to pregnant women, but potential benefits from use of the drug may be acceptable in certain conditions despite possible risks to the fetus.
Because of the potential for serious adverse reactions to carboplatin in nursing infants if the drug were distributed into milk, nursing should be discontinued during carboplatin therapy.